Holdings
Select Health Care Portfolio
As of May 31, 2026, Select Health Care Portfolio reported 100 positions worth US$5.53B. Largest: Eli Lilly And Company, Danaher Corporation and Johnson & Johnson. What it bought and sold, with each filing.
| Company | Shares | Value as reported | Change | As of |
|---|---|---|---|---|
| Eli Lilly And Company | 420K | US$464M | +12,000 | May 31, 2026 |
| Danaher Corporation | 2.18M | US$398M | +300K | May 31, 2026 |
| Johnson & Johnson | 1.26M | US$284M | −140K | May 31, 2026 |
| Thermo Fisher Scientific Inc | 508K | US$250M | +296K | May 31, 2026 |
| Unitedhealth Group Incorporated | 530K | US$202M | +250K | May 31, 2026 |
| Alnylam Pharmaceuticals, Inc. | 460K | US$139M | +120K | May 31, 2026 |
| Gilead Sciences, Inc. | 950K | US$128M | −130K | May 31, 2026 |
| Boston Scientific Corporation | 2.6M | US$126M | −2.25M | May 31, 2026 |
| Ascendis Pharma A/s | 560K | US$126M | −156K | May 31, 2026 |
| Abbvie Inc. | 540K | US$118M | −600K | May 31, 2026 |